9 June 2016Americas

BIO 2016 video interview: Applied StemCell's Dr Ruhong Jiang talks CRISPR/Cas9

In today’s video interview LSIPR speaks to Dr Ruhong Jiang, president of biotechnology company Applied StemCell, about its work with the CRISPR/Cas9 technology.

In 2014, Applied StemCell, announced that it had entered a licensing agreement with the Broad Institute of MIT and Harvard for use and commercialisation of CRISPR/Cas9 gene editing technology.

He talks to LSIPR about the influential technology.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk